Loading clinical trials...
Loading clinical trials...
In this study, patients presenting with acute infections at risk of developing sepsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a designated smartphone application. This is an innovative pilot study that will examine the potential of transmural care through telemonitoring for the first time in patients at risk for developing sepsis. By allowing for active follow-up of vital parameters in a transmural setting, this project aims to reduce the number of hospitalizations as compared to current practice. Furthermore, we aim to the number of patients referred to the emergency department after a visit at their primary care physician. Thereby, we aim to reduce the healthcare burden, yet providing the ability for rapid intervention in case of detarioration of patients, thereby reducing morbidity and mortality as well as associated costs.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Antwerp University Hospital (UZA)
Edegem, Antwerpen, Belgium
Start Date
February 1, 2025
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
April 10, 2025
120
ESTIMATED participants
(semi)continue monitoring of patients at risk for sepsis at home
OTHER
Lead Sponsor
University Hospital, Antwerp
NCT04929028
NCT06237452
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions